Brainstorm Cell Therapeutics Inc.
BCLI
$0.61
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -97.02% | -76.25% | 111.04% | -85.62% | -88.15% |
| Total Receivables | 100.00% | 221.21% | 157.69% | 23.53% | -39.39% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 171.15% | 86.31% | 36.78% | -75.36% | 183.64% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 39.56% | -60.30% | 85.23% | -79.73% | -76.35% |
|
|
|||||
| Total Current Assets | 39.56% | -60.30% | 85.23% | -79.73% | -76.35% |
| Net Property, Plant & Equipment | -57.68% | -50.48% | -45.15% | -40.88% | -64.63% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -100.00% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 25.62% | 13.07% | 0.99% | -0.48% | 866.67% |
| Total Assets | -31.85% | -54.85% | 6.66% | -56.46% | -64.36% |
|
|
|||||
| Total Accounts Payable | 39.47% | 12.30% | 44.93% | 22.73% | 17.24% |
| Total Accrued Expenses | -59.54% | -48.89% | -15.41% | -50.08% | 1,273.02% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -51.58% | -32.69% | -24.66% | -8.96% | -56.36% |
| Total Finance Division Other Current Liabilities | 79.69% | 57.64% | 109.71% | 42.57% | 1.75% |
| Total Other Current Liabilities | 79.69% | 57.64% | 109.71% | 42.57% | 1.75% |
| Total Current Liabilities | 27.41% | 10.88% | 59.58% | 15.10% | 12.04% |
|
|
|||||
| Total Current Liabilities | 27.41% | 10.88% | 59.58% | 15.10% | 12.04% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -81.55% | -76.01% | -76.17% | -74.55% | -82.90% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -24.75% | 103.63% |
| Total Liabilities | 12.26% | -6.37% | 23.94% | 5.85% | -2.20% |
|
|
|||||
| Common Stock & APIC | 4.23% | 4.10% | 4.31% | 4.15% | 5.20% |
| Retained Earnings | -4.85% | -5.18% | -5.08% | -5.41% | -6.79% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -27.01% | -71.73% | -34.36% | -59.82% | -134.59% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -27.01% | -71.73% | -34.36% | -59.82% | -134.59% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -27.01% | -71.73% | -34.36% | -59.82% | -134.59% |
|
|
|||||